THOMPSON DAVIS & CO., INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$2,0000.0%1250.0%0.00%
-20.0%
Q2 2018$2,0000.0%1250.0%0.01%0.0%
Q1 2018$2,0001250.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,340,193$227,22910.94%
Novo Holdings A/S 3,377,768$92,044,1786.80%
Parallel Advisors, LLC 3,723,483$101,446,2943.38%
TANAKA CAPITAL MANAGEMENT INC 37,569$1,0242.92%
S&T BANK/PA 334,252$9,1071.76%
Birchview Capital, LP 50,000$1,362,2501.16%
Granite Investment Partners, LLC 798,552$21,756,5490.91%
FAS Wealth Partners, Inc. 310,764$8,466,7660.90%
Clearview Wealth Advisors LLC 25,258$688,1550.85%
Bridge City Capital, LLC 43,485$1,184,7490.60%
View complete list of CORCEPT THERAPEUTICS INC shareholders